Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood

Arnold W. Strauss, Cynthia K. Powell, Daniel E. Hale, Melissa M. Anderson, Ajay Ahuja, Jeffrey C. Brackett, Harold F. Sims

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

β-Oxidation of long-chain fatty acids provides the major source of energy in the heart. Defects in enzymes of the β-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy. Very-long-chain acyl-CoA dehydrogenase [VLCAD; very-long-chain-acyl-CoA:(acceptor) 2,3-oxidoreductase, EC 1.3.99.13] catalyzes the first step in β-oxidation. We have isolated the human VLCAD cDNA and gene and determined the complete nucleotide sequences. Polymerase chain reaction amplification of VLCAD mRNA and genomic exons defined the molecular defects in two patients with VLCAD deficiency who presented with unexplained cardiac arrest and cardiomyopathy. In one, a homozygous mutation in the consensus dinucleotide of the donor splice site (g+1 → a) was associated with universal skipping of the prior exon (exon 11). The second patient was a compound heterozygote, with a missense mutation, C1837 → T, changing the arginine at residue 613 to tryptophan on one allele and a single base deletion at the intron-exon 6 boundary as the second mutation. This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid β-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.

Original languageEnglish (US)
Pages (from-to)10496-10500
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume92
Issue number23
DOIs
StatePublished - Nov 7 1995

Fingerprint

Long-Chain Acyl-CoA Dehydrogenase
Sudden Death
Cardiomyopathies
Exons
Acute Liver Failure
Mutation
Fatty Acids
Acyl Coenzyme A
RNA Splice Sites
Hepatic Encephalopathy
Muscular Diseases
Missense Mutation
Heterozygote
Heart Arrest
Tryptophan
Introns
Arginine
Oxidoreductases
Complementary DNA
Alleles

All Science Journal Classification (ASJC) codes

  • General

Cite this

Strauss, Arnold W. ; Powell, Cynthia K. ; Hale, Daniel E. ; Anderson, Melissa M. ; Ahuja, Ajay ; Brackett, Jeffrey C. ; Sims, Harold F. / Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. In: Proceedings of the National Academy of Sciences of the United States of America. 1995 ; Vol. 92, No. 23. pp. 10496-10500.
@article{935aa9ee2d6f45eaac02ae2464f4f81c,
title = "Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood",
abstract = "β-Oxidation of long-chain fatty acids provides the major source of energy in the heart. Defects in enzymes of the β-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy. Very-long-chain acyl-CoA dehydrogenase [VLCAD; very-long-chain-acyl-CoA:(acceptor) 2,3-oxidoreductase, EC 1.3.99.13] catalyzes the first step in β-oxidation. We have isolated the human VLCAD cDNA and gene and determined the complete nucleotide sequences. Polymerase chain reaction amplification of VLCAD mRNA and genomic exons defined the molecular defects in two patients with VLCAD deficiency who presented with unexplained cardiac arrest and cardiomyopathy. In one, a homozygous mutation in the consensus dinucleotide of the donor splice site (g+1 → a) was associated with universal skipping of the prior exon (exon 11). The second patient was a compound heterozygote, with a missense mutation, C1837 → T, changing the arginine at residue 613 to tryptophan on one allele and a single base deletion at the intron-exon 6 boundary as the second mutation. This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid β-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.",
author = "Strauss, {Arnold W.} and Powell, {Cynthia K.} and Hale, {Daniel E.} and Anderson, {Melissa M.} and Ajay Ahuja and Brackett, {Jeffrey C.} and Sims, {Harold F.}",
year = "1995",
month = "11",
day = "7",
doi = "10.1073/pnas.92.23.10496",
language = "English (US)",
volume = "92",
pages = "10496--10500",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "23",

}

Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. / Strauss, Arnold W.; Powell, Cynthia K.; Hale, Daniel E.; Anderson, Melissa M.; Ahuja, Ajay; Brackett, Jeffrey C.; Sims, Harold F.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, No. 23, 07.11.1995, p. 10496-10500.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood

AU - Strauss, Arnold W.

AU - Powell, Cynthia K.

AU - Hale, Daniel E.

AU - Anderson, Melissa M.

AU - Ahuja, Ajay

AU - Brackett, Jeffrey C.

AU - Sims, Harold F.

PY - 1995/11/7

Y1 - 1995/11/7

N2 - β-Oxidation of long-chain fatty acids provides the major source of energy in the heart. Defects in enzymes of the β-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy. Very-long-chain acyl-CoA dehydrogenase [VLCAD; very-long-chain-acyl-CoA:(acceptor) 2,3-oxidoreductase, EC 1.3.99.13] catalyzes the first step in β-oxidation. We have isolated the human VLCAD cDNA and gene and determined the complete nucleotide sequences. Polymerase chain reaction amplification of VLCAD mRNA and genomic exons defined the molecular defects in two patients with VLCAD deficiency who presented with unexplained cardiac arrest and cardiomyopathy. In one, a homozygous mutation in the consensus dinucleotide of the donor splice site (g+1 → a) was associated with universal skipping of the prior exon (exon 11). The second patient was a compound heterozygote, with a missense mutation, C1837 → T, changing the arginine at residue 613 to tryptophan on one allele and a single base deletion at the intron-exon 6 boundary as the second mutation. This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid β-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.

AB - β-Oxidation of long-chain fatty acids provides the major source of energy in the heart. Defects in enzymes of the β-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy. Very-long-chain acyl-CoA dehydrogenase [VLCAD; very-long-chain-acyl-CoA:(acceptor) 2,3-oxidoreductase, EC 1.3.99.13] catalyzes the first step in β-oxidation. We have isolated the human VLCAD cDNA and gene and determined the complete nucleotide sequences. Polymerase chain reaction amplification of VLCAD mRNA and genomic exons defined the molecular defects in two patients with VLCAD deficiency who presented with unexplained cardiac arrest and cardiomyopathy. In one, a homozygous mutation in the consensus dinucleotide of the donor splice site (g+1 → a) was associated with universal skipping of the prior exon (exon 11). The second patient was a compound heterozygote, with a missense mutation, C1837 → T, changing the arginine at residue 613 to tryptophan on one allele and a single base deletion at the intron-exon 6 boundary as the second mutation. This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid β-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.

UR - http://www.scopus.com/inward/record.url?scp=0028817917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028817917&partnerID=8YFLogxK

U2 - 10.1073/pnas.92.23.10496

DO - 10.1073/pnas.92.23.10496

M3 - Article

C2 - 7479827

AN - SCOPUS:0028817917

VL - 92

SP - 10496

EP - 10500

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 23

ER -